期刊文献+

HER2/neu过表达通过PI3K/Akt通路对乳腺癌细胞MCF7中p53基因表达及细胞生长和放疗敏感性的影响 被引量:19

The effect of HER2/neu overexpression on p53 gene expression, cell proliferation and sensitivity to γ-irradiation via the PI3K/Akt pathway in breast cancer cell MCF7
原文传递
导出
摘要 目的研究HER2/neu基因过表达通过磷脂酰肌醇3激酶(PI3K)通路对乳腺癌细胞MCF7野生型p53基因表达、细胞增殖及对γ射线照射敏感性的影响。方法以脂质体介导的HER2/neu基因转染MCF7细胞,用G418筛选阳性克隆。通过Westernblot鉴定HER2/neu蛋白的表达,并检测p53、信号转导分子Akt和pAkt蛋白含量的变化及PI3K通路抑制剂LY294002对上述蛋白表达水平的影响。以MTT法检测细胞增殖以及细胞对γ射线照射的敏感性。结果共获得18个稳定转染HER2/neu基因的阳性克隆,其中1个克隆有HER2/neu基因过表达。过表达HER2/neu的MCF7细胞pAkt蛋白含量升高,p53蛋白含量低于对照组细胞,LY294002能够抑制pAkt蛋白和p53蛋白的变化。同时,过表达HER2/neu基因的MCF7细胞生长速度高于对照组细胞,对γ射线照射治疗的敏感性降低,而LY294002能够抑制细胞生长并增强放射治疗的敏感性。结论MCF7细胞中HER2/neu基因的过表达,能够通过激活PI3K通路导致野生型p53蛋白含量减少、细胞增殖加快及放疗的敏感性降低,这可能是某些p53蛋白为野生型的肿瘤患者对治疗产生抗性的原因。 Objective To investigate the effect of HER2/neu overexpression on the wild p53 gene expression, cell proliferation and sensitivity to γ irradiation via phosphatidylinositol 3 kinase (PI3K) pathway in human breast cancer cell MCF7. Methods Lipofectin mediated gene transfection method was used to transfer HER2/neu into MCF7 cells. Expression of HER2/neu, p53, Akt and p Akt protein after PI3K pathway inhibitor LY294002 treatment was determined by Western blot. Cell proliferation and cell surviving fraction after γ irradiation treatment were assayed by MTT. Results Eighteen of HER2/neu stably transfected MCF7 cell clones were established, one of them was HER2/neu overexpressing. HER2/neu overexpressing MCF7 cells showed higher p Akt expression and lower p53 expression than those of parental MCF7 cells, which could be abrogated by LY294002. HER2/neu overexpressing MCF7 cells had higher proliferation rate and lower sensitivity to γ irradiation than those of parental MCF7 cells, which could be opposed by LY294002. Conclusion Overexpression of HER2/neu induces reduced expression of wild type p53 protein,relatively high cell proliferation and low sensitivity to γ irradiation in breast cancer cell MCF7 by activating PI3K/Akt pathway, which may contribute to therapeutic resistance in some breast cancer patients with wild type p53 gene status.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2004年第10期594-597,共4页 Chinese Journal of Oncology
关键词 过表达 HER2/NEU PI3K LY294002 治疗 Γ射线照射 乳腺癌细胞 MCF7细胞 阳性克隆 P53基因表达 HER2/neu Breast neoplasms MCF7 cells p53 gene phosphatidylinositol 3-kinase pathway
  • 相关文献

参考文献2

二级参考文献9

  • 1Zhou D,Oncogene,1989年,4卷,105页
  • 2Caraway KL,Cantley LC.A neu acquaintance for ErbB3 and ErbB4: a role for receptor heterodimerization in growth signaling.Cell,1994,78:5
  • 3Graus-Porta D,Beerli RR,Daly JM,et al.Erb-B-2,the preferred he terodimerization partner of all ErbB receptors,is a mediator of la-teral signal ing.EMBCO J,1997,16:1647
  • 4Hynes,NE,Stern DF.The biology of erbB-2/neu/HER2 and its role in cancer.Biochem Biophys Acta,1994,1198:165
  • 5Revillion F,Bonneterre J,Peyrat JP.ERBB2 oncogenes in human breast cancer and itsclinical significance.Eur J Cancer,1998,34:791
  • 6Lewis GD,Figari I,Fendly B,et al.Diffential responses of human cancer cell lines to anti-p185HER2 monoclonal antibodies.Cancer Immunol Immunotherapy ,1993,37:255
  • 7Hardy E,Santana H,Sosa A,et al.Recovery of biologically active proteinsd etected with imidazole-sodium Dodecyl sulfate-zine (reverse stain) on sodium D odecyl sulfate gel.Anal Biochem,1996,240:150
  • 8Vargas-Roig LM,Gago FE,Tello O,et al.C-erb-B2 (HER-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer,1999,84(2):129
  • 9Pegram MD,Pauletti G,Slamon DJ.HER-2/neu as a predictive marker of responses to breast cancer research.Breast Cancer Res Treat,1998,52(1):65

共引文献17

同被引文献227

引证文献19

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部